Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy
This report is about a patient with metastastic squamous cell cancer of the head and neck refractory to nivolumab monotherapy, who showed a remarkable response to combination therapy with nivolumab and ipilimumab over a period of 2 years, but developed serious renal failure and a Takotsubo cardiomyopathy.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiomyopathy | Food and Drug Administration (FDA) | Germany Health | Head and Neck Cancer | Heart | Kidney Cancer | Melanoma | Renal Cell Carcinoma | Renal Failure | Skin Cancer | Squamous Cell Carcinoma | Toxicology | Yervoy